EGFR inhibitors in the treatment of colorectal cancer
This ar cle discusses the use of EGFR inhibitors in the treatment of pa ents with colorectal cancer. The mechanisms of their ac on, specifi c manifesta ons of toxicity are considered. A review of current literature data on the use of both approved for clinical use (cetuximab, panitumumab) and an -EGF...
Main Authors: | M. В. Zabelin, A. D. Kaprin, A. A. Kostin, E. V. Gameeva, S. E. Varlamova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2018-09-01
|
Series: | Issledovaniâ i Praktika v Medicine |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/295 |
Similar Items
-
Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01) -
The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer
by: A. N. Toropovskiy, et al.
Published: (2022-11-01) -
COLON AND RECTAL CANCER ARE DIFFERENT TUMOR ENTITIES ACCORDING TO EPIDEMIOLOGY, CARCINOGENESIS, MOLECULAR- AND TUMOR BIOLOGY, PRIMARY AND SECONDARY PREVENTION: PRECLINICAL EVIDENCE
by: S. Jafarov, et al.
Published: (2018-09-01) -
Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01) -
The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01)